Using cancer registry data: Agreement in cause-of-death data between the Ontario Cancer Registry and a longitudinal study of breast cancer patients

Chronic Diseases in Canada

Volumn 30, Issue 1, 2009, Pages 16-19

  Brenner, Darren R ^a,b   Tammemagi M C ^c   Bull, S B ^a,b   Pinnaduwaje, D ^a   Andrulis, I L ^a,d  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c BROCK UNIVERSITY   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Breast neoplasms; Cause of death; Data collection; Data registries; Epidemiology methods; Ontario cancer registry; Vital statistics

Indexed keywords

ARTICLE; BREAST CANCER; CANADA; CANCER MORTALITY; CANCER REGISTRY; CAUSE OF DEATH; HUMAN; KAPPA STATISTICS; MAJOR CLINICAL STUDY; SENSITIVITY AND SPECIFICITY; SUPERIOR SAGITTAL SINUS; VITAL STATISTICS;

BREAST NEOPLASMS; CAUSE OF DEATH; FEMALE; HUMANS; NEOPLASMS; ONTARIO; PROSPECTIVE STUDIES; REGISTRIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 72149121269     PISSN: 02288699     EISSN: 14818523     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Marrett LD, Clarke EA, Hatcher J, Weir HK. Epidemiologic research using the Ontario Cancer Registry. Can J Public Health. 1986;77 Suppl 1:79-85. (Pubitemid 16074417)
2. Hilsenbeck SG. Quality control practices in centralized tumor registries in North America. J Clin Epidemiol. 1990;43(11):1201-1212
3. Robles SC, Marrett LD, Clarke EA, Risch HA. An application of capture-recapture methods to the estimation of completeness of cancer registration. J Clin Epidemiol. 1988;41(5):495-501.
4. McLaughlin JR, Kreiger N, Marrett LD, Holowaty EJ. Cancer incidence registration and trends in Ontario. Eur J Cancer. 1991;27(11):1520-1524
5. Holowaty E. Summarization of information from multiple data sources. In: Black R, Simonato, L, Storm, H, ed. Automated data collection in cancer registries. IARC Technical Report 32. Lyon: IART, 1998.
6. Hall S, Schulze K, Groome P, Mackillop W, Holowaty E. Using cancer registry data for survival studies: the example of the Ontario Cancer Registry. J Clin Epidemiol. 2006;59(1):67-76. (Pubitemid 41797477)
7. Andrulis IL, Bull SB, Blackstein ME, Sutherland D, Mak C, Sidlofsky S, Pritzker KP, Hartwick RW, Hanna W, Lickley L, Wilkinson R, Qizilbash A, Ambus U, Lipa M, Weizel H, Katz A, Baida M, Mariz S, Stoik G, Dacamara P, Strongitharm D, Geddie W, McCready D. neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group. J Clin Oncol. 1998;16(4):1340-1349
8. Schouten LJ, Jager JJ, van den Brandt PA. Quality of cancer registry data: a comparison of data provided by clinicians with those of registration personnel. Br J Cancer. 1993;68(5):974-977
9. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159-174